Profile
Huai Zheng Peng is currently the Chief Executive Officer at A&B (HK) Co. Ltd., Director at Neurelis, Inc., Director at Blueberry Therapeutics Ltd., Director at China Medical Venture Investment Hk Ltd., and Non-Executive Director at Cambridge United China Collaborations Ltd. Previously, he held positions such as Director-Corporate Finance & Head-Life Sciences at Seymour Pierce Ltd., Non-Executive Director at China Medstar Ltd., Independent Director at Helius Medical Technologies, Inc., and Non-Executive Director at Faron Pharmaceuticals Oy, Navamedic ASA, Destiny Pharma Plc, Biodexa Pharmaceuticals Plc, and Acticor Biotech SAS. He was also an Independent Non-Executive Director & GM at China Medical System Holdings Ltd. and a Partner at Northland Bancorp, Inc. Additionally, he worked as a Senior Manager at Reabourne Technology Investment Management Ltd. and as a Portfolio Manager at Close Asset Management (UK) Ltd. Dr. Peng received his undergraduate and graduate degrees from Hunan University of Chinese Medicine and his doctorate from UCL Medical School.
Huai Zheng Peng active positions
| Companies | Position | Start |
|---|---|---|
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development activities | Director/Board Member | - |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Director/Board Member | - |
A&B (HK) Co. Ltd.
A&B (HK) Co. Ltd. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes portable neuro-modulation stimulator device | Chief Executive Officer | - |
Cambridge United China Collaborations Ltd. | Director/Board Member | - |
China Medical Venture Investment Hk Ltd. | Director/Board Member | - |
Former positions of Huai Zheng Peng
| Companies | Position | End |
|---|---|---|
| DESY PHAR | Director/Board Member | 01/06/2022 |
| SOLANA COMPANY | Director/Board Member | 01/05/2020 |
| BIODEXA PHARMACEUTICALS PLC | Director/Board Member | 31/03/2020 |
Northland Bancorp, Inc.
Northland Bancorp, Inc. Investment ManagersFinance Northland Bancorp focuses primarily on real estate investments | Corporate Officer/Principal | 01/01/2012 |
| ░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Huai Zheng Peng
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Seymour Pierce Ltd.
Seymour Pierce Ltd. Investment Banks/BrokersFinance Provides corporate brokerage and finance services | Finance |
China Medstar Ltd.
China Medstar Ltd. Medical DistributorsDistribution Services Supplies and leases radiotherapy equipment | Distribution Services |
Solana Co.
Solana Co. Medical SpecialtiesHealth Technology Operates as a medical technology company focused on neurological wellness | Health Technology |
Reabourne Technology Investment Management Ltd.
Reabourne Technology Investment Management Ltd. Provides asset management | |
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Navamedic ASA
Navamedic ASA Medical DistributorsDistribution Services Operates as pharmaceutical company | Distribution Services |
Close Asset Management (UK) Ltd.
Close Asset Management (UK) Ltd. Investment ManagersFinance TrinityBridge is an active, long-term manager that offers a comprehensive range of asset classes, such as equities, bonds, unit trusts, property, commodities, currencies, structured products, and hedge funds. The firm invests globally, both directly and indirectly, and follows many investment strategies. They favor a diversified, multi-asset approach and delegate portfolios not directly related to their core competencies to boutique-sized firms with a proven track record. TrinityBridge focuses on real returns, the right balance of growth and income, and ways to preserve wealth with the use of intensive research to identify the strongest opportunities. The firm looks for attractively priced, high-quality companies with a business profile and a track record of growing shareholder value. | Finance |
China Medical System Holdings Ltd.
China Medical System Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes prescription drugs and pharmaceutical products | Health Technology |
Destiny Pharma Plc
Destiny Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops novel antimicrobial products | Health Technology |
Northland Bancorp, Inc.
Northland Bancorp, Inc. Investment ManagersFinance Northland Bancorp focuses primarily on real estate investments | Finance |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Health Technology |
Hunan University of Chinese Medicine
Hunan University of Chinese Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development activities | Health Technology |
A&B (HK) Co. Ltd.
A&B (HK) Co. Ltd. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes portable neuro-modulation stimulator device | Electronic Technology |
UCL Medical School
UCL Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acticor Biotech SAS
Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
China Medical Venture Investment Hk Ltd. | |
Cambridge United China Collaborations Ltd. |
- Stock Market
- Insiders
- Huai Zheng Peng
















